Immunome (IMNM) Asset Utilization Ratio (2023 - 2026)

Immunome (IMNM) has 4 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 83.58% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 83.58% YoY) and the FY2025 annual result came in at 0.02, down 67.68% from the prior year.
• Asset Utilization Ratio fell to 0.01 in Q1 2026, from 0.01 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q4 2023 to a low of 0.01 in Q1 2026.
• A 4-year average of 0.04 and a median of 0.04 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2025 — Asset Utilization Ratio grew 12.53% — and 2026, when it plunged 83.58%.
• Tracing IMNM's Asset Utilization Ratio over 4 years: stood at 0.12 in 2023, then slumped by 68.64% to 0.04 in 2024, then sank by 61.16% to 0.01 in 2025, then plunged by 56.38% to 0.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.